rs28934897
Variant summary
The NM_000431.4(MVK):c.1129G>A (p.Val377Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.0021 (AC=3,382) in the gnomAD database across 1,612,856 control chromosomes, including 4 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.00243. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000538050: Functional studies have shown reduced or undetectable mevalonate kinase activity and protein expression in affected individuals, indicating this variant likely affects protein stability and function (Houten et al., 1999)." and additional evidence is available in ClinVar. This exact variant is curated in the UniProt human variants database as Uncertain Significance; it is also listed as a COSMIC curated somatic variant.
Frequency
Consequence
NM_000431.4 missense
Scores
Clinical Significance
Conservation
Publications
- porokeratosis 3, disseminated superficial actinic typeInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- hyperimmunoglobulinemia D with periodic feverInheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
- mevalonate kinase deficiencyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- mevalonic aciduriaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, PanelApp Australia
- disseminated superficial actinic porokeratosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- porokeratosis of MibelliInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
Classification according to ACMG Germline Pathogenicity v2019
Our verdict: Likely_pathogenic. The variant received 8 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| PS3Functional studies show damaging effect | Well-established functional study supports damaging effect (PS3); SCV000538050: Functional studies have shown reduced or undetectable mevalonate kinase activity and protein expression in affected individuals, indicating this variant likely affects protein stability and function (Houten et al., 1999).; SCV000712172: It has been demonstrated to lead to reduced enzymatic activity in vitro (Houten 1999).; SCV003928976: The variant is associated with an MK activity of approximately 40% of WT in E.coli lysates and that it was undetectable by immunoblot in fibroblast lysates from HIDS patients, suggesting it also impacts protein stability (Houten_1999).; SCV006584319: "Functional studies provide moderate evidence of the variant having a damaging effect on the gene or gene product (PMID: 10369261)."; SCV000279123: Published functional studies indicate that p.(V377I) leads to a decrease in enzyme activity and decreased stability when expressed in E. coli (Houten et al., 1999);; SCV001548926: "However, functional studies expressing cDNA constructs containing the V325I variant in E. coli have demonstrated decreased mevalonate kinase (MK) protein activity compared to wildtype (Houten_1999_PMID:10369261). Decreased MK activity was also found in lymphocytes and fibroblasts from patients with the V325I variant (Houten_1999_PMID:10369261)."; SCV000634151: Experimental studies have shown that this missense change affects MVK function (PMID: 10369261, 26977311).; SCV003740446: Functional studies showed that this alteration results in reduced enzyme activity (Houten, 1999; Messer, 2016).; SCV005397680: Studies examining the functional consequence of this variant have found reduced or undetectable mevalonate kinase activity and MK protein expression in affected individuals (PMID: 10369261).; SCV005399255: "This variant has strong functional evidence supporting abnormal protein function. Immunoblot analysis of patient lymphocytes showed minimal MK activity (PMID: 10369261)." | ||
| PP5Reputable source reports pathogenic | ClinVar 2-star pathogenic — strong (PP5); ClinVar submissions overwhelmingly pathogenic (≥10 total, ≥80% P/LP, <10% B/LB) — strong (PP5, count-based); ClinVar germline classification: Pathogenic/Likely Pathogenic, 2 star(s). ClinVar submissions strongly and reliably favor pathogenicity (52/52 total P/LP). |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_000431.4. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MVK | MANE Select | c.1129G>A | p.Val377Ile | missense | Exon 11 of 11 | NP_000422.1 | B2RDU6 | ||
| MVK | c.1204G>A | p.Val402Ile | missense | Exon 12 of 12 | NP_001401441.1 | ||||
| MVK | c.1129G>A | p.Val377Ile | missense | Exon 11 of 11 | NP_001107657.1 | Q03426 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MVK | TSL:1 MANE Select | c.1129G>A | p.Val377Ile | missense | Exon 11 of 11 | ENSP00000228510.3 | Q03426 | ||
| MVK | TSL:5 | c.1129G>A | p.Val377Ile | missense | Exon 11 of 11 | ENSP00000438153.2 | Q03426 | ||
| MVK | c.1129G>A | p.Val377Ile | missense | Exon 11 of 11 | ENSP00000548365.1 | Q03426 |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 6 sources | |||||
GnomAD3 genomes | AF: 0.00147 | AC:223 | Hom:1 | AN:152196 | Cov:33 |
GnomAD2 exomes | AF: 0.00158 | AC:393 | AN:249414 | ||
GnomAD4 exome | AF: 0.00216 | AC:3159 | Hom:3 | AN:1460542 | Cov:31 |
GnomAD4 genome | AF: 0.00146 | AC:223 | Hom:1 | AN:152314 | Cov:33 |
TOPMed (Bravo) | AF: 0.00134 | AC:354 | Hom:0 | AN:264690 | |
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.00162 | AC:765 | Hom:1 | AN:471894 | |
Local & regional cohorts 7 sources | |||||
ABraOM SABE-WGS-1171 | AF: 0.00256 | AC:6 | Hom:0 | AN:2342 | |
ChinaMAP Phase 1 | AF: 0.0000985 | ||||
ESP6500 (Exome Variant Server) | AF: 0.00169 | AC:22 | AN:13006 | ||
Qatari Genome | AF: 0.00320 | AC:6 | AN:1868 | ||
Turkish Variome | AF: 0.00360 | AC:24 | Hom:0 | AN:6662 | |
UK10K | AF: 0.00357 | AC:27 | AN:7562 | ||
WBBC (Westlake BioBank for Chinese) pilot | AF: 0.000112 | AC:1 | Hom:0 | AN:8960 | |
Case/control cohorts
| Cohort | Cases | Controls | ||||
|---|---|---|---|---|---|---|
| AF | AC | AN | AF | AC | AN | |
ASC | 0.00144 * | 16 | 11112 | 0.00131 * | 23 | 17618 |
BipEx | 0.00236 | 67 | 28420 | 0.00194 | 56 | 28844 |
Epi25 | 0.00176 | 74 | 41958 | 0.00199 | 133 | 66888 |
SCHEMA | 0.00116 | 136 | 117240 | 0.00113 | 206 | 181816 |
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Benign | 7.2 | |
AlphaMissense | Benign | 0.097 | |
BayesDel_addAF | Benign | -0.063 | T |
BayesDel_noAF | Pathogenic | 0.14 | |
CADD | Benign | 14 | |
DANN | Uncertain | 0.98 | |
DEOGEN2 | Benign | 0.24 | T |
Eigen | Benign | -0.41 | |
Eigen_PC | Benign | -0.37 | |
FATHMM_MKL | Uncertain | 0.93 | D |
FuncVEP CTI | Benign | 0.023 | |
GPN-Star LLR | N/A | -2.4 | |
GPN-Star score | N/A | 2.4 | |
LIST_S2 | Benign | 0.83 | T |
M_CAP | Uncertain | 0.086 | D |
MetaRNN | Benign | 0.020 | T |
MetaSVM | Uncertain | 0.071 | D |
Mutation Taster | N/A | 11/89 | disease causing (ClinVar) |
MutationAssessor | Uncertain | 2.0 | M |
PhyloP100 | Uncertain | 5.1 | |
popEVE | Benign | -3.1 | |
PrimateAI | Benign | 0.29 | T |
PROVEAN | Benign | -0.86 | N |
REVEL | Uncertain | 0.55 | |
Sift | Benign | 0.10 | T |
Sift4G | Uncertain | 0.036 | D |
Varity_R | N/A | 0.095 | |
VESM-3B | Benign | -6.2 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.0 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.